Supernus Pharmaceuticals Inc (SUPN)
R&D Expense Growth
-25.29%
Quarterly · Period ending:
SUPN R&D Expense Growth
Latest reported-25.29%period ending
Latest reported-25.29%period ending
SUPN Quarterly R&D Growth (QoQ) (0.00% → -25.29%)
Latest values, visible window
High-resolution chart · PNG
SUPN r&d expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| -25.2929% | |
| 41.7257% | |
| -5.2408% | |
| 32.7877% | |
| -17.8705% | |
| -6.0041% | |
| -1.3397% | |
| 10.8964% | |
| 5.0261% | |
| 6.7803% | |
| 3.0545% | |
| -7.0717% | |
| 14.9302% | |
| 19.3429% | |
| -9.103% | |
| 19.3409% | |
| -21.3734% | |
| -1.1339% | |
| 7.2453% | |
| 27.1692% | |
| -54.9154% | |
| 91.1027% | |
| 6.5265% | |
| -24.3089% | |
| 17.479% | |
| -4.3199% | |
| 16.8152% | |
| -0.1591% | |
| 10.2378% | |
| -48.4133% | |
| 46.1218% | |
| 1.9164% | |
| 5.9763% | |
| 16.9109% | |
| 24.5994% | |
| 19.9298% | |
| 12.7278% | |
| -27.5506% | |
| 68.4291% | |
| -29.1745% | |
| 5.1789% | |
| 11.8145% | |
| 3.4725% | |
| 32.7275% | |
| 86.7499% | |
| -36.192% | |
| 23.9425% | |
| -0.4276% | |
| 4.3507% | |
| -17.0307% | |
| 42.9479% | |
| 6.6911% | |
| -21.6718% | |
| -12.1942% | |
| -37.9966% | |
| 76.6107% | |
| -12.2247% | |
| -28.56% | |
| -10.9792% | |
| 16.1909% | |
| -2.6842% | |
| -17.8437% | |
| 0% | |
| 0% | |
| 0% |